Cargando…
Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies
Chemotherapy and targeted therapy are the major treatments for gastric cancer (GC), but drug resistance limits its effectiveness. Here, we profile the proteome of 206 tumor tissues from patients with GC undergoing either chemotherapy or anti-HER2-based therapy. Proteome-based classification reveals...
Autores principales: | Li, Yan, Xu, Chen, Wang, Bing, Xu, Fujiang, Ma, Fahan, Qu, Yuanyuan, Jiang, Dongxian, Li, Kai, Feng, Jinwen, Tian, Sha, Wu, Xiaohui, Wang, Yunzhi, Liu, Yang, Qin, Zhaoyu, Liu, Yalan, Qin, Jing, Song, Qi, Zhang, Xiaolei, Sujie, Akesu, Huang, Jie, Liu, Tianshu, Shen, Kuntang, Zhao, Jian-Yuan, Hou, Yingyong, Ding, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522856/ https://www.ncbi.nlm.nih.gov/pubmed/36175412 http://dx.doi.org/10.1038/s41467-022-33282-0 |
Ejemplares similares
-
Author Correction: Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies
por: Li, Yan, et al.
Publicado: (2022) -
High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients
por: Song, Qi, et al.
Publicado: (2017) -
Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2017) -
Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ
por: Yao, Zhenmei, et al.
Publicado: (2023) -
Integrated proteogenomic characterization of urothelial carcinoma of the bladder
por: Xu, Ning, et al.
Publicado: (2022)